Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02564263
Brief Title: Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

First Submitted : September 29, 2015
First Submitted that Met QC Criteria : September 29, 2015
First Posted : September 30, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 6, 2019
Last Update Posted : May 8, 2019